APS.TO | Aptose Biosciences Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2023	2022	2021	2020	2019	2018
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	52.35 Million	42.6 Million	65.44 Million	55.76 Million	26.85 Million	29.1 Million
Selling, General and Administrative Expenses	15.59 Million	14.43 Million	19.32 Million	26.34 Million	9.9 Million	10.32 Million
Research and Development Expenses	36.76 Million	28.08 Million	45.98 Million	29.28 Million	16.83 Million	18.73 Million
Other Expenses	-	81 Thousand	138 Thousand	135 Thousand	122 Thousand	53 Thousand
Cost and Expenses	52.35 Million	42.6 Million	65.44 Million	55.76 Million	26.85 Million	29.1 Million
Operating Income	-52.35 Million	-42.59 Million	-65.44 Million	-55.77 Million	-26.86 Million	-29.06 Million
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	-770 Thousand	-93 Thousand	-530 Thousand	-580 Thousand	-195 Thousand
Earnings before Tax	-51.2 Million	-41.82 Million	-65.35 Million	-55.23 Million	-26.27 Million	-28.86 Million
Net Income	-51.2 Million	-41.05 Million	-65.26 Million	-54.7 Million	-25.69 Million	-28.86 Million
Earnings Per Share Basic	-7.58	-0.44	-10.99	-10.03	-7.68	-12.97
Earnings Per Share Diluted	-7.58	-0.44	-10.99	-10.03	-7.68	-12.97
Weighted Average Shares Outstanding	6.75 Million	92.26 Million	5.93 Million	5.45 Million	3.34 Million	2.22 Million
Weighted Average Shares Outstanding (Diluted)	6.75 Million	92.26 Million	5.93 Million	5.45 Million	3.34 Million	2.22 Million
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-52.26 Million	-42.06 Million	-64.82 Million	-55.16 Million	-26.25 Million	-29.02 Million
Earnings Before Tax Margin	-	-	-	-	-	-

Breakdown	2024 Q2	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2
Revenue	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-
Operating Expenses	7.34 Million	9.76 Million	12.12 Million	52.35 Million	11.68 Million	14.45 Million
Selling, General and Administrative Expenses	2.92 Million	3.3 Million	3 Million	-	3.41 Million	3.85 Million
Research and Development Expenses	4.41 Million	6.44 Million	9.11 Million	-	8.25 Million	10.58 Million
Other Expenses	5000.00	-	-	-	-	-
Cost and Expenses	7.34 Million	9.76 Million	12.12 Million	52.35 Million	11.68 Million	14.45 Million
Operating Income	-7.34 Million	-9.75 Million	-12.12 Million	-52.35 Million	-11.68 Million	-14.44 Million
Interest Expense	-	-	-	-	-	-
Income Tax Expense	-	-120 Thousand	-172 Thousand	-	-234 Thousand	-323 Thousand
Earnings before Tax	-7.25 Million	-9.64 Million	-11.95 Million	-51.2 Million	-11.44 Million	-14.12 Million
Net Income	-7.25 Million	-9.64 Million	-11.95 Million	-51.2 Million	-11.44 Million	-14.12 Million
Earnings Per Share Basic	-0.43	-0.73	-1525.07	-	-1.76	-34.00
Earnings Per Share Diluted	-0.43	-0.73	-1523.51	-	-1.76	-34.00
Weighted Average Shares Outstanding	16.75 Million	13.13 Million	7839.00	6.75 Million	6.49 Million	415.6 Thousand
Weighted Average Shares Outstanding (Diluted)	16.75 Million	13.13 Million	7847.00	6.75 Million	6.49 Million	415.6 Thousand
Gross Margin	-	-	-	-	-	-
EBIT Margin	-	-	-	-	-	-
Profit Margin	-	-	-	-	-	-
EBITDA	-7.24 Million	-9.65 Million	-12.01 Million	-	-11.57 Million	-14.33 Million
Earnings Before Tax Margin	-	-	-	-	-	-